Cross Country Healthcare, Inc. (CCRN) 10-Year Financial Performance & Capital Metrics

CCRN • • Industrial / General

HealthcareHealthcare FacilitiesHealthcare Staffing & Workforce SolutionsHealthcare Staffing Agencies

AboutCross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.Show more

Revenue $1.34B -33.5%
EBITDA $635K -99.5%
Net Income -$15M -120.0%
EPS (Diluted) -0.44 -121.5%
Gross Margin 20.41% -8.5%
EBITDA Margin 0.05% -99.3%
Operating Margin -1.25% -122.5%
Net Margin -1.08% -130.1%
ROE -3.26% -120.9%
ROIC -3.15% -120.0%
Debt/Equity 0.01 -17.0%
Interest Coverage -7.71 -155.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 20.5%
✓Strong 5Y sales CAGR of 10.3%
✓Share count reduced 5.9% through buybacks
✓Trading at only 0.7x book value
✓Efficient asset utilization: 2.3x turnover

✗Weaknesses

✗Weak momentum: RS Rating 8 (bottom 8%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y8.08%

5Y10.33%

3Y-7.11%

TTM-22.14%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-788.16%

EPS CAGR

10Y-

5Y-

3Y-

TTM-792.53%

ROCE

10Y Avg9.65%

5Y Avg18.33%

3Y Avg19.98%

Latest-3.37%

Peer Comparison

Healthcare Staffing Agencies

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AMNAMN Healthcare Services, Inc.	588.5M	15.32	-3.98	-21.26%	-10.14%	-42.76%	40.7%	1.55
CCRNCross Country Healthcare, Inc.	276.82M	8.45	-19.20	-33.46%	-1.39%	-3.84%	40.24%	0.01

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	767.42M	833.54M	865.05M	816.48M	822.22M	836.42M	1.68B	2.8B	2.02B	1.34B
Revenue Growth %	0.24%	0.09%	0.04%	-0.06%	0.01%	0.02%	1%	0.67%	-0.28%	-0.33%
Cost of Goods Sold+	570.06M	611.8M	636.46M	606.92M	618.22M	633.68M	1.3B	2.18B	1.57B	1.07B
COGS % of Revenue	0.74%	0.73%	0.74%	0.74%	0.75%	0.76%	0.78%	0.78%	0.78%	0.8%
Gross Profit+	197.37M	221.74M	228.59M	209.56M	204.01M	202.73M	375M	624.46M	450.41M	274.25M
Gross Margin %	0.26%	0.27%	0.26%	0.26%	0.25%	0.24%	0.22%	0.22%	0.22%	0.2%
Gross Profit Growth %	0.25%	0.12%	0.03%	-0.08%	-0.03%	-0.01%	0.85%	0.67%	-0.28%	-0.39%
Operating Expenses+	169.34M	189M	197.61M	192.01M	219.72M	211.89M	235.69M	354.58M	337.7M	291.12M
OpEx % of Revenue	0.22%	0.23%	0.23%	0.24%	0.27%	0.25%	0.14%	0.13%	0.17%	0.22%
Selling, General & Admin	162.27M	180.41M	189.26M	182.43M	183.97M	176.84M	220.04M	324.21M	314.95M	254.81M
SG&A % of Revenue	0.21%	0.22%	0.22%	0.22%	0.22%	0.21%	0.13%	0.12%	0.16%	0.19%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	306K	230K	155K	418K	35.75M	35.05M	15.65M	30.37M	22.74M	36.31M
Operating Income+	20.57M	6.18M	11.75M	-12.88M	-15.71M	-9.16M	139.3M	269.88M	112.71M	-16.86M
Operating Margin %	0.03%	0.01%	0.01%	-0.02%	-0.02%	-0.01%	0.08%	0.1%	0.06%	-0.01%
Operating Income Growth %	2.96%	-0.7%	0.9%	-2.1%	-0.22%	0.42%	16.21%	0.94%	-0.58%	-1.15%
EBITDA+	28.63M	15.37M	21.92M	-1.1M	-4.54M	411K	148.76M	282.46M	131.06M	635K
EBITDA Margin %	0.04%	0.02%	0.03%	-0%	-0.01%	0%	0.09%	0.1%	0.06%	0%
EBITDA Growth %	10.46%	-0.46%	0.43%	-1.05%	-3.12%	1.09%	360.94%	0.9%	-0.54%	-1%
D&A (Non-Cash Add-back)	8.07M	9.18M	10.17M	11.78M	11.18M	9.57M	9.45M	12.58M	18.35M	17.5M
EBIT	27.02M	32.14M	8.52M	-12.54M	8.87M	16.32M	145.1M	267.49M	110.99M	-725K
Net Interest Income+	-6.81M	-6.11M	-4.21M	-5.65M	-5.31M	-2.89M	-6.87M	-14.38M	-8.09M	-138K
Interest Income	0	0	0	0	0	0	0	10K	0	2.05M
Interest Expense	6.81M	6.11M	4.21M	5.65M	5.31M	2.89M	6.87M	14.39M	8.09M	2.19M
Other Income/Expense	-16.41M	-1.64M	-7.45M	-5.32M	-8.5M	-3.17M	-6.1M	-16.78M	-9.82M	467K
Pretax Income+	4.16M	4.54M	4.3M	-18.2M	-24.21M	-12.33M	133.21M	253.1M	102.89M	-16.4M
Pretax Margin %	0.01%	0.01%	0%	-0.02%	-0.03%	-0.01%	0.08%	0.09%	0.05%	-0.01%
Income Tax+	-794K	-4.19M	-34.5M	-2.48M	31.73M	-188K	1.21M	67.11M	30.26M	-1.84M
Effective Tax Rate %	1.06%	1.75%	8.72%	0.93%	2.38%	1.05%	0.99%	0.73%	0.71%	0.89%
Net Income+	4.42M	7.97M	37.51M	-16.95M	-57.71M	-12.96M	132M	185.98M	72.63M	-14.56M
Net Margin %	0.01%	0.01%	0.04%	-0.02%	-0.07%	-0.02%	0.08%	0.07%	0.04%	-0.01%
Net Income Growth %	1.14%	0.8%	3.71%	-1.45%	-2.4%	0.78%	11.18%	0.41%	-0.61%	-1.2%
Net Income (Continuing)	4.95M	8.73M	38.8M	-15.72M	-55.94M	-12.14M	132M	185.98M	72.63M	-14.56M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	496K	559K	630K	670K	868K	534K	0	0	0	0
EPS (Diluted)+	0.14	0.15	1.01	-0.48	-1.56	-0.34	3.53	5.02	2.05	-0.44
EPS Growth %	1.14%	0.07%	5.73%	-1.48%	-2.25%	0.78%	11.38%	0.42%	-0.59%	-1.21%
EPS (Basic)	0.14	0.25	1.07	-0.48	-1.56	-0.34	3.60	5.09	2.07	-0.44
Diluted Shares Outstanding	32.16M	36.25M	36.17M	35.66M	35.81M	36.09M	37.39M	37.54M	35.48M	33.38M
Basic Shares Outstanding	31.51M	32.13M	35.02M	35.31M	35.81M	36.09M	36.69M	37.01M	35.16M	33.38M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	158.75M	205.61M	208.89M	194.91M	183.36M	183.11M	508.27M	675.67M	415.15M	335M
Cash & Short-Term Investments	2.45M	20.63M	25.54M	16.02M	1.03M	1.6M	1.04M	3.6M	17.09M	81.63M
Cash Only	2.45M	20.63M	25.54M	16.02M	1.03M	1.6M	1.04M	3.6M	17.09M	81.63M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	149.74M	176.66M	177.1M	170.31M	174.54M	174.7M	498.95M	659.96M	388.35M	242.88M
Days Sales Outstanding	71.22	77.36	74.73	76.14	77.48	76.24	108.62	85.93	70.18	65.96
Inventory	4.52M	6.13M	5.29M	6.21M	0	0	0	11.07M	0	0
Days Inventory Outstanding	2.89	3.65	3.03	3.73	-	-	-	1.85	-	-
Other Current Assets	2.03M	2.2M	963K	2.36M	1.69M	1.35M	638K	1.04M	2.03M	2.64M
Total Non-Current Assets+	207.35M	182.77M	258.8M	232.1M	199.02M	173.86M	224.54M	272.17M	264.16M	254.25M
Property, Plant & Equipment	10.47M	12.82M	14.09M	13.63M	28.94M	22.9M	23.38M	22.92M	29.94M	31.32M
Fixed Asset Turnover	73.30x	65.03x	61.41x	59.91x	28.41x	36.52x	71.72x	122.33x	67.46x	42.91x
Goodwill	95.1M	79.65M	117.59M	101.06M	101.07M	90.92M	119.49M	163.27M	135.43M	135.06M
Intangible Assets	82.91M	72.24M	87.68M	75.58M	50.86M	40.73M	48.24M	44.72M	54.47M	42.19M
Long-Term Investments	17.99M	16.21M	17.2M	16.19M	0	0	14.67M	23.78M	33K	0
Other Non-Current Assets	-88K	507K	2.03M	1.89M	18.15M	19.31M	7.23M	10.38M	38.34M	37.58M
Total Assets+	366.1M	388.38M	467.69M	427M	382.37M	356.97M	732.81M	947.84M	679.32M	589.25M
Asset Turnover	2.10x	2.15x	1.85x	1.91x	2.15x	2.34x	2.29x	2.96x	2.97x	2.28x
Asset Growth %	0.13%	0.06%	0.2%	-0.09%	-0.1%	-0.07%	1.05%	0.29%	-0.28%	-0.13%
Total Current Liabilities+	86.05M	97.09M	94.59M	85.39M	85.47M	93.42M	199.77M	271.64M	148.59M	120.4M
Accounts Payable	41.1M	43.36M	50.6M	43.74M	45.73M	49.88M	109.75M	12.86M	3.04M	5.74M
Days Payables Outstanding	26.31	25.87	29.02	26.31	27	28.73	30.78	2.15	0.71	1.96
Short-Term Debt	8.07M	2.26M	6.88M	5.24M	0	2.42M	8.27M	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	0	0	0	0	0	0
Other Current Liabilities	7.47M	2.75M	2.85M	3.08M	14.38M	12.66M	8.86M	154.98M	127M	28.76M
Current Ratio	1.84x	2.12x	2.21x	2.28x	2.15x	1.96x	2.54x	2.49x	2.79x	2.78x
Quick Ratio	1.79x	2.05x	2.15x	2.21x	2.15x	1.96x	2.54x	2.45x	2.79x	2.78x
Cash Conversion Cycle	47.8	55.14	48.74	53.56	-	-	-	85.63	-	-
Total Non-Current Liabilities+	138.71M	139.48M	135.38M	123.42M	133.41M	108.64M	235.51M	218.98M	57.34M	49.89M
Long-Term Debt	81.3M	84.75M	92.26M	77.94M	70.97M	55.83M	176.37M	148.74M	0	0
Capital Lease Obligations	0	10K	0	0	19.07M	15.23M	10.85M	4.88M	2.66M	1.78M
Deferred Tax Liabilities	18.48M	13.15M	105K	95K	7.52M	6.59M	190K	247K	401K	566K
Other Non-Current Liabilities	38.93M	41.57M	43.02M	45.38M	35.84M	30.98M	48.1M	65.12M	54.27M	47.54M
Total Liabilities	224.75M	236.58M	229.97M	208.81M	218.87M	202.06M	435.28M	490.62M	205.92M	170.29M
Total Debt+	89.87M	87.02M	99.13M	83.18M	94.92M	78M	195.49M	157.75M	5.27M	3.87M
Net Debt	87.42M	66.39M	73.6M	67.16M	93.89M	76.4M	194.45M	154.14M	-11.83M	-77.76M
Debt / Equity	0.64x	0.57x	0.42x	0.38x	0.58x	0.50x	0.66x	0.35x	0.01x	0.01x
Debt / EBITDA	3.14x	5.66x	4.52x	-	-	189.79x	1.31x	0.56x	0.04x	6.10x
Net Debt / EBITDA	3.05x	4.32x	3.36x	-	-	185.89x	1.31x	0.55x	-0.09x	-122.46x
Interest Coverage	3.02x	1.01x	2.79x	-2.28x	-2.96x	-3.17x	20.29x	18.75x	13.93x	-7.71x
Total Equity+	141.34M	151.8M	237.72M	218.2M	163.5M	154.91M	297.53M	457.22M	473.39M	418.96M
Equity Growth %	0.08%	0.07%	0.57%	-0.08%	-0.25%	-0.05%	0.92%	0.54%	0.04%	-0.11%
Book Value per Share	4.39	4.19	6.57	6.12	4.57	4.29	7.96	12.18	13.34	12.55
Total Shareholders' Equity	140.85M	151.24M	237.09M	217.53M	162.63M	154.38M	297.53M	457.22M	473.39M	418.96M
Common Stock	3K	3K	4K	4K	4K	4K	4K	4K	4K	3K
Retained Earnings	-112.06M	-104.09M	-67.11M	-84.06M	-141.78M	-154.74M	-22.73M	165.73M	238.36M	218.06M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-1.21M	-1.24M	-1.17M	-1.46M	-1.24M	-1.28M	-1.29M	-1.39M	-1.39M	-1.44M
Minority Interest	496K	559K	630K	670K	868K	534K	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	18.23M	30.14M	45.51M	21M	5.54M	27.2M	-85.62M	134.05M	248.5M	120.12M
Operating CF Margin %	0.02%	0.04%	0.05%	0.03%	0.01%	0.03%	-0.05%	0.05%	0.12%	0.09%
Operating CF Growth %	5.48%	0.65%	0.51%	-0.54%	-0.74%	3.91%	-4.15%	2.57%	0.85%	-0.52%
Net Income	4.95M	8.73M	38.8M	-15.72M	-55.94M	-12.14M	132M	185.98M	72.63M	-14.56M
Depreciation & Amortization	8.07M	9.18M	10.17M	11.78M	14.07M	12.67M	9.85M	12.58M	18.35M	18.2M
Stock-Based Compensation	2.46M	3.38M	4.08M	3.58M	3.4M	5.4M	6.89M	7.39M	6.58M	6.03M
Deferred Taxes	-1.54M	-5.32M	-33.81M	-3.41M	31.16M	-932K	-9.93M	5.11M	1.3M	-1.94M
Other Non-Cash Items	17.87M	26.61M	23.17M	32.16M	27.03M	25.05M	12.82M	26.7M	22.16M	24.77M
Working Capital Changes	-13.57M	-12.44M	3.1M	-7.39M	-14.17M	-2.85M	-237.26M	-103.71M	127.48M	87.63M
Change in Receivables	-28.71M	-30.78M	9.71M	2.82M	-6.64M	-4.75M	-318.42M	-153.23M	251.43M	128.33M
Change in Inventory	3.55M	-1.53M	1.82M	7.09M	1.31M	-7.24M	-83.29M	0	0	0
Change in Payables	11.21M	20.37M	-9.28M	-7.09M	-1.31M	7.24M	83.29M	0	-126.61M	-29.75M
Cash from Investing+	-24.07M	-9.78M	-91.38M	-6.68M	-2.94M	-4.62M	-34.05M	-43.87M	-13.78M	-8.71M
Capital Expenditures	-2.36M	-6.52M	-5.11M	-4.6M	-2.94M	-4.62M	-7.17M	-8.79M	-13.97M	-8.71M
CapEx % of Revenue	0%	0.01%	0.01%	0.01%	0%	0.01%	0%	0%	0.01%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-338K	500K	-292K	-151K	1.57M	1.15M	0	0	0	0
Cash from Financing+	3.35M	-2.16M	50.76M	-23.77M	-17.6M	-22.01M	119.09M	-87.6M	-221.24M	-46.85M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-1.15M	-3.66M	-4.74M	-2.64M	-1.84M	-1.28M	-6.35M	-84.65M	-12.91M	-9.54M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	15.87M	23.62M	40.4M	16.4M	2.6M	22.59M	-92.79M	125.26M	234.52M	111.4M
FCF Margin %	0.02%	0.03%	0.05%	0.02%	0%	0.03%	-0.06%	0.04%	0.12%	0.08%
FCF Growth %	2.84%	0.49%	0.71%	-0.59%	-0.84%	7.68%	-5.11%	2.35%	0.87%	-0.52%
FCF per Share	0.49	0.65	1.12	0.46	0.07	0.63	-2.48	3.34	6.61	3.34
FCF Conversion (FCF/Net Income)	4.13x	3.78x	1.21x	-1.24x	-0.10x	-2.10x	-0.65x	0.72x	3.42x	-8.25x
Interest Paid	5.05M	3.89M	3.41M	6.34M	4.55M	2.67M	5.77M	12.86M	7.53M	0
Taxes Paid	1.03M	1.77M	697K	1.04M	555K	612K	3.61M	82.89M	21.99M	2.43M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	3.25%	5.44%	19.26%	-7.44%	-30.24%	-8.14%	58.35%	49.28%	15.61%	-3.26%
Return on Invested Capital (ROIC)	7.2%	2.08%	3.33%	-3.24%	-4.34%	-2.81%	28.89%	36.69%	15.76%	-3.15%
Gross Margin	25.72%	26.6%	26.42%	25.67%	24.81%	24.24%	22.37%	22.28%	22.3%	20.41%
Net Margin	0.58%	0.96%	4.34%	-2.08%	-7.02%	-1.55%	7.87%	6.63%	3.6%	-1.08%
Debt / Equity	0.64x	0.57x	0.42x	0.38x	0.58x	0.50x	0.66x	0.35x	0.01x	0.01x
Interest Coverage	3.02x	1.01x	2.79x	-2.28x	-2.96x	-3.17x	20.29x	18.75x	13.93x	-7.71x
FCF Conversion	4.13x	3.78x	1.21x	-1.24x	-0.10x	-2.10x	-0.65x	0.72x	3.42x	-8.25x
Revenue Growth	24.21%	8.62%	3.78%	-5.61%	0.7%	1.73%	100.46%	67.2%	-27.95%	-33.46%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Other Services	-	-	-	-	-	-	-	-	56.16M	41.65M
Other Services Growth	-	-	-	-	-	-	-	-	-	-25.84%
Nurse And Allied Staffing	621.26M	721.49M	758.27M	720.3M	732.82M	757.95M	1.61B	2.7B	-	-
Nurse And Allied Staffing Growth	-	16.13%	5.10%	-5.01%	1.74%	3.43%	111.86%	68.17%	-	-
Physician Staffing	115.34M	98.28M	93.61M	82.31M	74.61M	67.93M	70.87M	106.23M	-	-
Physician Staffing Growth	-	-14.79%	-4.75%	-12.08%	-9.36%	-8.94%	4.32%	49.89%	-	-
Search Services	-	-	-	-	14.8M	10.53M	-	-	-	-
Search Services Growth	-	-	-	-	-	-28.84%	-	-	-	-
Other Human Capital Management Services	30.83M	13.77M	13.17M	13.88M	-	-	-	-	-	-
Other Human Capital Management Services Growth	-	-55.34%	-4.34%	5.36%	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Cross Country Healthcare, Inc. (CCRN) reported $1.13B in revenue for fiscal year 2024. This represents a 124% increase from $504.0M in 2011.

Cross Country Healthcare, Inc. (CCRN) saw revenue decline by 33.5% over the past year.

Cross Country Healthcare, Inc. (CCRN) reported a net loss of $15.7M for fiscal year 2024.

Dividend & Returns

Cross Country Healthcare, Inc. (CCRN) has a return on equity (ROE) of -3.3%. Negative ROE indicates the company is unprofitable.

Cross Country Healthcare, Inc. (CCRN) generated $45.7M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Cross Country Healthcare, Inc. (CCRN) 10-Year Financial Performance & Capital Metrics

CCRN • • Industrial / General

HealthcareHealthcare FacilitiesHealthcare Staffing & Workforce SolutionsHealthcare Staffing Agencies

Revenue $1.34B -33.5%
EBITDA $635K -99.5%
Net Income -$15M -120.0%
EPS (Diluted) -0.44 -121.5%
Gross Margin 20.41% -8.5%
EBITDA Margin 0.05% -99.3%
Operating Margin -1.25% -122.5%
Net Margin -1.08% -130.1%
ROE -3.26% -120.9%
ROIC -3.15% -120.0%
Debt/Equity 0.01 -17.0%
Interest Coverage -7.71 -155.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 20.5%
✓Strong 5Y sales CAGR of 10.3%
✓Share count reduced 5.9% through buybacks
✓Trading at only 0.7x book value
✓Efficient asset utilization: 2.3x turnover

✗Weaknesses

✗Weak momentum: RS Rating 8 (bottom 8%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y8.08%

5Y10.33%

3Y-7.11%

TTM-22.14%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-788.16%

EPS CAGR

10Y-

5Y-

3Y-

TTM-792.53%

ROCE

10Y Avg9.65%

5Y Avg18.33%

3Y Avg19.98%

Latest-3.37%

Peer Comparison

Healthcare Staffing Agencies

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AMNAMN Healthcare Services, Inc.	588.5M	15.32	-3.98	-21.26%	-10.14%	-42.76%	40.7%	1.55
CCRNCross Country Healthcare, Inc.	276.82M	8.45	-19.20	-33.46%	-1.39%	-3.84%	40.24%	0.01

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	767.42M	833.54M	865.05M	816.48M	822.22M	836.42M	1.68B	2.8B	2.02B	1.34B
Revenue Growth %	0.24%	0.09%	0.04%	-0.06%	0.01%	0.02%	1%	0.67%	-0.28%	-0.33%
Cost of Goods Sold+	570.06M	611.8M	636.46M	606.92M	618.22M	633.68M	1.3B	2.18B	1.57B	1.07B
COGS % of Revenue	0.74%	0.73%	0.74%	0.74%	0.75%	0.76%	0.78%	0.78%	0.78%	0.8%
Gross Profit+	197.37M	221.74M	228.59M	209.56M	204.01M	202.73M	375M	624.46M	450.41M	274.25M
Gross Margin %	0.26%	0.27%	0.26%	0.26%	0.25%	0.24%	0.22%	0.22%	0.22%	0.2%
Gross Profit Growth %	0.25%	0.12%	0.03%	-0.08%	-0.03%	-0.01%	0.85%	0.67%	-0.28%	-0.39%
Operating Expenses+	169.34M	189M	197.61M	192.01M	219.72M	211.89M	235.69M	354.58M	337.7M	291.12M
OpEx % of Revenue	0.22%	0.23%	0.23%	0.24%	0.27%	0.25%	0.14%	0.13%	0.17%	0.22%
Selling, General & Admin	162.27M	180.41M	189.26M	182.43M	183.97M	176.84M	220.04M	324.21M	314.95M	254.81M
SG&A % of Revenue	0.21%	0.22%	0.22%	0.22%	0.22%	0.21%	0.13%	0.12%	0.16%	0.19%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	306K	230K	155K	418K	35.75M	35.05M	15.65M	30.37M	22.74M	36.31M
Operating Income+	20.57M	6.18M	11.75M	-12.88M	-15.71M	-9.16M	139.3M	269.88M	112.71M	-16.86M
Operating Margin %	0.03%	0.01%	0.01%	-0.02%	-0.02%	-0.01%	0.08%	0.1%	0.06%	-0.01%
Operating Income Growth %	2.96%	-0.7%	0.9%	-2.1%	-0.22%	0.42%	16.21%	0.94%	-0.58%	-1.15%
EBITDA+	28.63M	15.37M	21.92M	-1.1M	-4.54M	411K	148.76M	282.46M	131.06M	635K
EBITDA Margin %	0.04%	0.02%	0.03%	-0%	-0.01%	0%	0.09%	0.1%	0.06%	0%
EBITDA Growth %	10.46%	-0.46%	0.43%	-1.05%	-3.12%	1.09%	360.94%	0.9%	-0.54%	-1%
D&A (Non-Cash Add-back)	8.07M	9.18M	10.17M	11.78M	11.18M	9.57M	9.45M	12.58M	18.35M	17.5M
EBIT	27.02M	32.14M	8.52M	-12.54M	8.87M	16.32M	145.1M	267.49M	110.99M	-725K
Net Interest Income+	-6.81M	-6.11M	-4.21M	-5.65M	-5.31M	-2.89M	-6.87M	-14.38M	-8.09M	-138K
Interest Income	0	0	0	0	0	0	0	10K	0	2.05M
Interest Expense	6.81M	6.11M	4.21M	5.65M	5.31M	2.89M	6.87M	14.39M	8.09M	2.19M
Other Income/Expense	-16.41M	-1.64M	-7.45M	-5.32M	-8.5M	-3.17M	-6.1M	-16.78M	-9.82M	467K
Pretax Income+	4.16M	4.54M	4.3M	-18.2M	-24.21M	-12.33M	133.21M	253.1M	102.89M	-16.4M
Pretax Margin %	0.01%	0.01%	0%	-0.02%	-0.03%	-0.01%	0.08%	0.09%	0.05%	-0.01%
Income Tax+	-794K	-4.19M	-34.5M	-2.48M	31.73M	-188K	1.21M	67.11M	30.26M	-1.84M
Effective Tax Rate %	1.06%	1.75%	8.72%	0.93%	2.38%	1.05%	0.99%	0.73%	0.71%	0.89%
Net Income+	4.42M	7.97M	37.51M	-16.95M	-57.71M	-12.96M	132M	185.98M	72.63M	-14.56M
Net Margin %	0.01%	0.01%	0.04%	-0.02%	-0.07%	-0.02%	0.08%	0.07%	0.04%	-0.01%
Net Income Growth %	1.14%	0.8%	3.71%	-1.45%	-2.4%	0.78%	11.18%	0.41%	-0.61%	-1.2%
Net Income (Continuing)	4.95M	8.73M	38.8M	-15.72M	-55.94M	-12.14M	132M	185.98M	72.63M	-14.56M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	496K	559K	630K	670K	868K	534K	0	0	0	0
EPS (Diluted)+	0.14	0.15	1.01	-0.48	-1.56	-0.34	3.53	5.02	2.05	-0.44
EPS Growth %	1.14%	0.07%	5.73%	-1.48%	-2.25%	0.78%	11.38%	0.42%	-0.59%	-1.21%
EPS (Basic)	0.14	0.25	1.07	-0.48	-1.56	-0.34	3.60	5.09	2.07	-0.44
Diluted Shares Outstanding	32.16M	36.25M	36.17M	35.66M	35.81M	36.09M	37.39M	37.54M	35.48M	33.38M
Basic Shares Outstanding	31.51M	32.13M	35.02M	35.31M	35.81M	36.09M	36.69M	37.01M	35.16M	33.38M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	158.75M	205.61M	208.89M	194.91M	183.36M	183.11M	508.27M	675.67M	415.15M	335M
Cash & Short-Term Investments	2.45M	20.63M	25.54M	16.02M	1.03M	1.6M	1.04M	3.6M	17.09M	81.63M
Cash Only	2.45M	20.63M	25.54M	16.02M	1.03M	1.6M	1.04M	3.6M	17.09M	81.63M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	149.74M	176.66M	177.1M	170.31M	174.54M	174.7M	498.95M	659.96M	388.35M	242.88M
Days Sales Outstanding	71.22	77.36	74.73	76.14	77.48	76.24	108.62	85.93	70.18	65.96
Inventory	4.52M	6.13M	5.29M	6.21M	0	0	0	11.07M	0	0
Days Inventory Outstanding	2.89	3.65	3.03	3.73	-	-	-	1.85	-	-
Other Current Assets	2.03M	2.2M	963K	2.36M	1.69M	1.35M	638K	1.04M	2.03M	2.64M
Total Non-Current Assets+	207.35M	182.77M	258.8M	232.1M	199.02M	173.86M	224.54M	272.17M	264.16M	254.25M
Property, Plant & Equipment	10.47M	12.82M	14.09M	13.63M	28.94M	22.9M	23.38M	22.92M	29.94M	31.32M
Fixed Asset Turnover	73.30x	65.03x	61.41x	59.91x	28.41x	36.52x	71.72x	122.33x	67.46x	42.91x
Goodwill	95.1M	79.65M	117.59M	101.06M	101.07M	90.92M	119.49M	163.27M	135.43M	135.06M
Intangible Assets	82.91M	72.24M	87.68M	75.58M	50.86M	40.73M	48.24M	44.72M	54.47M	42.19M
Long-Term Investments	17.99M	16.21M	17.2M	16.19M	0	0	14.67M	23.78M	33K	0
Other Non-Current Assets	-88K	507K	2.03M	1.89M	18.15M	19.31M	7.23M	10.38M	38.34M	37.58M
Total Assets+	366.1M	388.38M	467.69M	427M	382.37M	356.97M	732.81M	947.84M	679.32M	589.25M
Asset Turnover	2.10x	2.15x	1.85x	1.91x	2.15x	2.34x	2.29x	2.96x	2.97x	2.28x
Asset Growth %	0.13%	0.06%	0.2%	-0.09%	-0.1%	-0.07%	1.05%	0.29%	-0.28%	-0.13%
Total Current Liabilities+	86.05M	97.09M	94.59M	85.39M	85.47M	93.42M	199.77M	271.64M	148.59M	120.4M
Accounts Payable	41.1M	43.36M	50.6M	43.74M	45.73M	49.88M	109.75M	12.86M	3.04M	5.74M
Days Payables Outstanding	26.31	25.87	29.02	26.31	27	28.73	30.78	2.15	0.71	1.96
Short-Term Debt	8.07M	2.26M	6.88M	5.24M	0	2.42M	8.27M	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	0	0	0	0	0	0
Other Current Liabilities	7.47M	2.75M	2.85M	3.08M	14.38M	12.66M	8.86M	154.98M	127M	28.76M
Current Ratio	1.84x	2.12x	2.21x	2.28x	2.15x	1.96x	2.54x	2.49x	2.79x	2.78x
Quick Ratio	1.79x	2.05x	2.15x	2.21x	2.15x	1.96x	2.54x	2.45x	2.79x	2.78x
Cash Conversion Cycle	47.8	55.14	48.74	53.56	-	-	-	85.63	-	-
Total Non-Current Liabilities+	138.71M	139.48M	135.38M	123.42M	133.41M	108.64M	235.51M	218.98M	57.34M	49.89M
Long-Term Debt	81.3M	84.75M	92.26M	77.94M	70.97M	55.83M	176.37M	148.74M	0	0
Capital Lease Obligations	0	10K	0	0	19.07M	15.23M	10.85M	4.88M	2.66M	1.78M
Deferred Tax Liabilities	18.48M	13.15M	105K	95K	7.52M	6.59M	190K	247K	401K	566K
Other Non-Current Liabilities	38.93M	41.57M	43.02M	45.38M	35.84M	30.98M	48.1M	65.12M	54.27M	47.54M
Total Liabilities	224.75M	236.58M	229.97M	208.81M	218.87M	202.06M	435.28M	490.62M	205.92M	170.29M
Total Debt+	89.87M	87.02M	99.13M	83.18M	94.92M	78M	195.49M	157.75M	5.27M	3.87M
Net Debt	87.42M	66.39M	73.6M	67.16M	93.89M	76.4M	194.45M	154.14M	-11.83M	-77.76M
Debt / Equity	0.64x	0.57x	0.42x	0.38x	0.58x	0.50x	0.66x	0.35x	0.01x	0.01x
Debt / EBITDA	3.14x	5.66x	4.52x	-	-	189.79x	1.31x	0.56x	0.04x	6.10x
Net Debt / EBITDA	3.05x	4.32x	3.36x	-	-	185.89x	1.31x	0.55x	-0.09x	-122.46x
Interest Coverage	3.02x	1.01x	2.79x	-2.28x	-2.96x	-3.17x	20.29x	18.75x	13.93x	-7.71x
Total Equity+	141.34M	151.8M	237.72M	218.2M	163.5M	154.91M	297.53M	457.22M	473.39M	418.96M
Equity Growth %	0.08%	0.07%	0.57%	-0.08%	-0.25%	-0.05%	0.92%	0.54%	0.04%	-0.11%
Book Value per Share	4.39	4.19	6.57	6.12	4.57	4.29	7.96	12.18	13.34	12.55
Total Shareholders' Equity	140.85M	151.24M	237.09M	217.53M	162.63M	154.38M	297.53M	457.22M	473.39M	418.96M
Common Stock	3K	3K	4K	4K	4K	4K	4K	4K	4K	3K
Retained Earnings	-112.06M	-104.09M	-67.11M	-84.06M	-141.78M	-154.74M	-22.73M	165.73M	238.36M	218.06M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-1.21M	-1.24M	-1.17M	-1.46M	-1.24M	-1.28M	-1.29M	-1.39M	-1.39M	-1.44M
Minority Interest	496K	559K	630K	670K	868K	534K	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	18.23M	30.14M	45.51M	21M	5.54M	27.2M	-85.62M	134.05M	248.5M	120.12M
Operating CF Margin %	0.02%	0.04%	0.05%	0.03%	0.01%	0.03%	-0.05%	0.05%	0.12%	0.09%
Operating CF Growth %	5.48%	0.65%	0.51%	-0.54%	-0.74%	3.91%	-4.15%	2.57%	0.85%	-0.52%
Net Income	4.95M	8.73M	38.8M	-15.72M	-55.94M	-12.14M	132M	185.98M	72.63M	-14.56M
Depreciation & Amortization	8.07M	9.18M	10.17M	11.78M	14.07M	12.67M	9.85M	12.58M	18.35M	18.2M
Stock-Based Compensation	2.46M	3.38M	4.08M	3.58M	3.4M	5.4M	6.89M	7.39M	6.58M	6.03M
Deferred Taxes	-1.54M	-5.32M	-33.81M	-3.41M	31.16M	-932K	-9.93M	5.11M	1.3M	-1.94M
Other Non-Cash Items	17.87M	26.61M	23.17M	32.16M	27.03M	25.05M	12.82M	26.7M	22.16M	24.77M
Working Capital Changes	-13.57M	-12.44M	3.1M	-7.39M	-14.17M	-2.85M	-237.26M	-103.71M	127.48M	87.63M
Change in Receivables	-28.71M	-30.78M	9.71M	2.82M	-6.64M	-4.75M	-318.42M	-153.23M	251.43M	128.33M
Change in Inventory	3.55M	-1.53M	1.82M	7.09M	1.31M	-7.24M	-83.29M	0	0	0
Change in Payables	11.21M	20.37M	-9.28M	-7.09M	-1.31M	7.24M	83.29M	0	-126.61M	-29.75M
Cash from Investing+	-24.07M	-9.78M	-91.38M	-6.68M	-2.94M	-4.62M	-34.05M	-43.87M	-13.78M	-8.71M
Capital Expenditures	-2.36M	-6.52M	-5.11M	-4.6M	-2.94M	-4.62M	-7.17M	-8.79M	-13.97M	-8.71M
CapEx % of Revenue	0%	0.01%	0.01%	0.01%	0%	0.01%	0%	0%	0.01%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-338K	500K	-292K	-151K	1.57M	1.15M	0	0	0	0
Cash from Financing+	3.35M	-2.16M	50.76M	-23.77M	-17.6M	-22.01M	119.09M	-87.6M	-221.24M	-46.85M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-1.15M	-3.66M	-4.74M	-2.64M	-1.84M	-1.28M	-6.35M	-84.65M	-12.91M	-9.54M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	15.87M	23.62M	40.4M	16.4M	2.6M	22.59M	-92.79M	125.26M	234.52M	111.4M
FCF Margin %	0.02%	0.03%	0.05%	0.02%	0%	0.03%	-0.06%	0.04%	0.12%	0.08%
FCF Growth %	2.84%	0.49%	0.71%	-0.59%	-0.84%	7.68%	-5.11%	2.35%	0.87%	-0.52%
FCF per Share	0.49	0.65	1.12	0.46	0.07	0.63	-2.48	3.34	6.61	3.34
FCF Conversion (FCF/Net Income)	4.13x	3.78x	1.21x	-1.24x	-0.10x	-2.10x	-0.65x	0.72x	3.42x	-8.25x
Interest Paid	5.05M	3.89M	3.41M	6.34M	4.55M	2.67M	5.77M	12.86M	7.53M	0
Taxes Paid	1.03M	1.77M	697K	1.04M	555K	612K	3.61M	82.89M	21.99M	2.43M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	3.25%	5.44%	19.26%	-7.44%	-30.24%	-8.14%	58.35%	49.28%	15.61%	-3.26%
Return on Invested Capital (ROIC)	7.2%	2.08%	3.33%	-3.24%	-4.34%	-2.81%	28.89%	36.69%	15.76%	-3.15%
Gross Margin	25.72%	26.6%	26.42%	25.67%	24.81%	24.24%	22.37%	22.28%	22.3%	20.41%
Net Margin	0.58%	0.96%	4.34%	-2.08%	-7.02%	-1.55%	7.87%	6.63%	3.6%	-1.08%
Debt / Equity	0.64x	0.57x	0.42x	0.38x	0.58x	0.50x	0.66x	0.35x	0.01x	0.01x
Interest Coverage	3.02x	1.01x	2.79x	-2.28x	-2.96x	-3.17x	20.29x	18.75x	13.93x	-7.71x
FCF Conversion	4.13x	3.78x	1.21x	-1.24x	-0.10x	-2.10x	-0.65x	0.72x	3.42x	-8.25x
Revenue Growth	24.21%	8.62%	3.78%	-5.61%	0.7%	1.73%	100.46%	67.2%	-27.95%	-33.46%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Other Services	-	-	-	-	-	-	-	-	56.16M	41.65M
Other Services Growth	-	-	-	-	-	-	-	-	-	-25.84%
Nurse And Allied Staffing	621.26M	721.49M	758.27M	720.3M	732.82M	757.95M	1.61B	2.7B	-	-
Nurse And Allied Staffing Growth	-	16.13%	5.10%	-5.01%	1.74%	3.43%	111.86%	68.17%	-	-
Physician Staffing	115.34M	98.28M	93.61M	82.31M	74.61M	67.93M	70.87M	106.23M	-	-
Physician Staffing Growth	-	-14.79%	-4.75%	-12.08%	-9.36%	-8.94%	4.32%	49.89%	-	-
Search Services	-	-	-	-	14.8M	10.53M	-	-	-	-
Search Services Growth	-	-	-	-	-	-28.84%	-	-	-	-
Other Human Capital Management Services	30.83M	13.77M	13.17M	13.88M	-	-	-	-	-	-
Other Human Capital Management Services Growth	-	-55.34%	-4.34%	5.36%	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Cross Country Healthcare, Inc. (CCRN) reported $1.13B in revenue for fiscal year 2024. This represents a 124% increase from $504.0M in 2011.

Cross Country Healthcare, Inc. (CCRN) saw revenue decline by 33.5% over the past year.

Cross Country Healthcare, Inc. (CCRN) reported a net loss of $15.7M for fiscal year 2024.

Dividend & Returns

Cross Country Healthcare, Inc. (CCRN) has a return on equity (ROE) of -3.3%. Negative ROE indicates the company is unprofitable.

Cross Country Healthcare, Inc. (CCRN) generated $45.7M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.